Abstract
Bleomycin labeled with 57Co was used as a tumor localizing agent in 132 patients. In patients with pulmonary tumors the primary localization concentrated radioactivity in 52 of the 54 appropriate cases; out of the 22 clinically known metastases, 19 were visible on the scan; 40 unknown metastases especially in hilus and mediastinum were found by this method and subsequently confirmed. In 22 patients with malignant lymphomas, 18 out of 22 known pathologic lymph glands above the diaphragm were visible on the scan; below the diaphragm the results of scanning in lymph glands and spleen were disappointing, probably because of the disturbing concentration of radioactivity in the kidneys, the bladder, the liver, and sometimes the gut. In 25 patients with various other tumors, 16 out of 22 known localizations above the diaphragm were visible; 2 were uncertain and 4 negative. Below the diaphragm the results were usually negative. In 24 patients with benign lesions, uptake of 57Co bleomycin was visible on the scintigram in 4 patients with cavitating pulmonary tuberculosis, in 2 with pulmonary infections, in 1 with Caplan lesions of rheumatoid arthritis in the lung, and in 1 with sinusitis ethmoidalis. The significance of these results is discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 1058-1069 |
| Number of pages | 12 |
| Journal | Journal of nuclear medicine |
| Volume | 16 |
| Issue number | 11 |
| Publication status | Published - 1 Jan 1975 |
| Externally published | Yes |
Fingerprint
Cite this
}
Some experience with 57Co labeled bleomycin as a tumor seeking agent. / Rasker, J.J.; van de Poll, M.A.P.C.; Beekhuis, H.; Woldring, M.G.; Nieweg, H.O.
In: Journal of nuclear medicine, Vol. 16, No. 11, 01.01.1975, p. 1058-1069.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Some experience with 57Co labeled bleomycin as a tumor seeking agent
AU - Rasker, J.J.
AU - van de Poll, M.A.P.C.
AU - Beekhuis, H.
AU - Woldring, M.G.
AU - Nieweg, H.O.
PY - 1975/1/1
Y1 - 1975/1/1
N2 - Bleomycin labeled with 57Co was used as a tumor localizing agent in 132 patients. In patients with pulmonary tumors the primary localization concentrated radioactivity in 52 of the 54 appropriate cases; out of the 22 clinically known metastases, 19 were visible on the scan; 40 unknown metastases especially in hilus and mediastinum were found by this method and subsequently confirmed. In 22 patients with malignant lymphomas, 18 out of 22 known pathologic lymph glands above the diaphragm were visible on the scan; below the diaphragm the results of scanning in lymph glands and spleen were disappointing, probably because of the disturbing concentration of radioactivity in the kidneys, the bladder, the liver, and sometimes the gut. In 25 patients with various other tumors, 16 out of 22 known localizations above the diaphragm were visible; 2 were uncertain and 4 negative. Below the diaphragm the results were usually negative. In 24 patients with benign lesions, uptake of 57Co bleomycin was visible on the scintigram in 4 patients with cavitating pulmonary tuberculosis, in 2 with pulmonary infections, in 1 with Caplan lesions of rheumatoid arthritis in the lung, and in 1 with sinusitis ethmoidalis. The significance of these results is discussed.
AB - Bleomycin labeled with 57Co was used as a tumor localizing agent in 132 patients. In patients with pulmonary tumors the primary localization concentrated radioactivity in 52 of the 54 appropriate cases; out of the 22 clinically known metastases, 19 were visible on the scan; 40 unknown metastases especially in hilus and mediastinum were found by this method and subsequently confirmed. In 22 patients with malignant lymphomas, 18 out of 22 known pathologic lymph glands above the diaphragm were visible on the scan; below the diaphragm the results of scanning in lymph glands and spleen were disappointing, probably because of the disturbing concentration of radioactivity in the kidneys, the bladder, the liver, and sometimes the gut. In 25 patients with various other tumors, 16 out of 22 known localizations above the diaphragm were visible; 2 were uncertain and 4 negative. Below the diaphragm the results were usually negative. In 24 patients with benign lesions, uptake of 57Co bleomycin was visible on the scintigram in 4 patients with cavitating pulmonary tuberculosis, in 2 with pulmonary infections, in 1 with Caplan lesions of rheumatoid arthritis in the lung, and in 1 with sinusitis ethmoidalis. The significance of these results is discussed.
UR - http://www.scopus.com/inward/record.url?scp=0016589374&partnerID=8YFLogxK
M3 - Article
VL - 16
SP - 1058
EP - 1069
JO - Journal of nuclear medicine
JF - Journal of nuclear medicine
SN - 0161-5505
IS - 11
ER -